1. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin,1998
2. Points To Consider in the Manufacture and Testing of Monoclonal Antibody Products For Human Use,1997
3. Control of Microbiological Contamination. In Code of Federal Regulations, vol. 21, part 211.113, Food and Drug Administration, USA, 2002.